FUTUREDME
FuturedMe mission is to bring each medicine to each patient who does not have any medicine.
FUTUREDME
Industry:
Biotechnology Health Care
Founded:
2018-06-26
Address:
Tokyo, Tokyo, Japan
Country:
Japan
Website Url:
http://www.futuredme.com
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics Global Site Tag
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.futuredme.com
- Host name: sv7765.xserver.jp
- IP address: 183.181.79.126
- Location: Osaka Japan
- Latitude: 34.6848
- Longitude: 135.5142
- Timezone: Asia/Tokyo
- Postal: 543-0062
More informations about "FuturedMe"
FuturedMe Inc.
FuturedMe is a pioneer in the science of using CANDDY™ Platform—new protein degradation platform—to make new small molecules as drug candidates. CANDDY™ technology has …See details»
株式会社FuturedMe | 株式会社FuturedMe
Apr 1, 2019 FuturedMeのミッションは、「今、薬がない人に薬をとどける(No patients without medicine)」です。CANDDY™プラットフォーム（タンパク質分解創薬プラットフォーム） …See details»
FuturedMe - Crunchbase Company Profile & Funding
FuturedMe is a biotechnology firm that uses targeted protein degradation technology to develop medicines for every disease. ... Chrome Extension. Solutions. Products. Resources. Pricing. …See details»
FuturedMe Company Profile 2024: Valuation, Funding & Investors
FuturedMe General Information Description. Developer of target protein degradation technology designed to develop and provide medicine for every disease. The company's platform has in …See details»
FuturedMe Inc. | NEDO
Phase Business Area/Field Research Period Research Grant Amount; STS: Healthcare: 2023～2025FY: JPY 61 millionSee details»
FUTUREDME INC. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for FUTUREDME INC. of KASHIWA, CHIBA. Get the latest business insights from Dun & Bradstreet.See details»
株式会社FuturedMe - smrj.go.jp
株式会社FuturedMe 事業展開 FuturedMeは、2つのビジネスモデルを持つ。 一つは、自社創薬事業で、インハウスでアンドラッガ ブルターゲットのファーストイン創薬を目指している。 …See details»
FuturedMe - Products, Competitors, Financials, Employees, …
FuturedMe is a biotechnology company focused on drug design and development using its proprietary CANDDY™ technology. The company specializes in creating small molecule drug …See details»
FuturedMe - Contacts, Employees, Board Members, Advisors
FuturedMe mission is to bring each medicine to each patient who does not have any medicine.See details»
FuturedMe - Tech Stack, Apps, Patents & Trademarks - Crunchbase
FuturedMe mission is to bring each medicine to each patient who does not have any medicine.See details»
株式会社FuturedMe | NEDO
株式会社FuturedMe CANDDYによる疾患特異的分解創薬支援プラットフォーム構築See details»
FuturedMe Inc. - VentureRadar
SciKon creates life science products that replicate the performance of human organ systems using benchtop microfluidic devices. Products simulate pharmacokinetics to evaluate...See details»
We would like to inform you the recent change of President and ...
Apr 21, 2022 Representative Director Takashi Yokokura retired from FuturedMe Inc. and Dr. Etsuko Miyamoto, the founder of FuturedMe Inc. was assigned the position of President and …See details»
大学発ベンチャー FuturedMe 日本発の分解創薬プラットフォーム …
Dec 22, 2023 株式会社FuturedMeのプレスリリース（2023年12月22日 14時54分）大学発ベンチャー FuturedMe 日本発の分解創薬プラットフォーム CANDDYで NEDO「ディープ ...See details»
株式会社FuturedMeの会社情報と資金調達 | NIKKEI COMPASS - 日 …
大学発ベンチャー FuturedMe 日本発の分解創薬プラットフォーム CANDDYで NEDO「ディープテック・スタートアップ支援事業」に採択決定[FuturedMe ...See details»
CANDDY技術で創薬の世界にゲームチェンジを起こす【株式会社F…
Oct 10, 2024 宮本悦子FuturedMe代表 同社はNEDOのSTSフェーズにおける研究開発が順調に進み、次のPCAフェーズでの事業化に向けて新たな資金調達を計画している。See details»
株式会社FuturedMe - スピーダ スタートアップ情報 ...
Jul 30, 2024 独自の創薬技術「CANDDY」の研究開発を行う。 「CANDDY」は、生体内のタンパク質分解現象を利用し、小分子を用いて標的タンパク質を分解に誘導する創薬技術。 ユ …See details»
治療標的に対応する薬がない！という現状を変えたい 創薬の革新 …
Jun 23, 2022 株式会社 FuturedMe は、生体に備わるタンパク質分解機能を利用する、東京理科大学発（日本発）の創薬プラットフォーム技術" CANDDY "を土台として、 2018 年に設立 …See details»
FuturedMe was introduced in Nikkei Sangyo Shimbun | FuturedMe …
Jun 6, 2019 FuturedMe was introduced in Nikkei Sangyo Shimbun as “a start-up challenging to develop a new treatment for pancreatic cancer by breaking down proteins of interest based on …See details»
We held the 2024 Kickoff Dinner! | FuturedMe Inc.
Jan 26, 2024 Wishing you and your family a wonderful 2024 from all of us at FuturedMe Inc. We had a kickoff dinner with everyone from KSP Corporation and our members! previousSee details»